Sign inJoin waitlistJoin the waitlist

Navya Nair

Program Director, Gynecologic Oncology Fellowship · Jackson Memorial Hospital

Credentials: · · · · · ·

History

Gynecologic Oncology Fellowship · Jackson Memorial Hospital
Present
University of Miami/Jackson Health System Fellowship
Present
Gynecologic Oncology Fellowship · University of Miami/Jackson Health System
Present

Gynecologic Oncology
Mount Sinai Hospital
2015–2018
Obstetrics and Gynecology
Emory University School of Medicine
2011–2015
New York University Grossman School of Medicine
2007–2011

Research

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
PLoS ONE · 2015 · 152 citations
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of…
PLoS Medicine · 2016 · First of 18 authors · 80 citations
Antioxidants Associated With Oncogenic Human Papillomavirus Infection in Women
The Journal of Infectious Diseases · 2021 · 25 citations

Amelia Jernigan
7 papers
Tara Castellano
4 papers
Abdulrahman Sinno
3 papers
Matthew Schlumbrecht
3 papers
Peter Dottino
3 papers
AB
Ann Beddoe
2 papers
EP
Elena Pereira
2 papers · 2 as a fellow
Eloise Chapman-Davis
2 papers
Humza Pirzadah
2 papers
Jeffrey Hines
2 papers
JM
John Martignetti
2 papers
SM
Shawna Morron
2 papers

Clinical trials

Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy
Principal investigator · Recruiting · Phase 2
University of Miami
2026–2031
Fasting InTervention for Endometrial Cancer
Site PI · Recruiting
University of Miami
2026–2028
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030